Combining Rosuvastatin with Sartans of Different Peroxisome Proliferator-Activated Receptor-γ Activating Capacity Is Not Associated with Different Changes in Low-Density Lipoprotein Subfractions and Plasma Lipoprotein-Associated Phospholipase A2-Reference-Cited by-同舟云学术

Combining Rosuvastatin with Sartans of Different Peroxisome Proliferator-Activated Receptor-γ Activating Capacity Is Not Associated with Different Changes in Low-Density Lipoprotein Subfractions and Plasma Lipoprotein-Associated Phospholipase A2

Published:2011-06 Issue:3 Volume:9 Page:217-223
ISSN:1540-4196
Container-title:Metabolic Syndrome and Related Disorders
language:en
Short-container-title:Metabolic Syndrome and Related Disorders

Author:

Rizos Christos V.¹,Liberopoulos Evangelos N.¹,Tellis Constantinos C.²,Florentin Matilda¹,Elisaf Moses S.¹,Tselepis Alexandros D.²

Affiliation:

1. Department of Internal Medicine, School of Medicine, University of Ioannina, Ioannina, Greece.

2. Laboratory of Biochemistry, School of Chemistry, University of Ioannina, Ioannina, Greece.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/met.2010.0120

Reference30 articles.

1. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

2. Identification of multiple subclasses of plasma low density lipoproteins in normal humans.

3. Low-density lipoprotein size and cardiovascular risk assessment

4. Τhe role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma

5. Distribution of PAF-acetylhydrolase activity in human plasma low-density lipoprotein subfractions

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association between dietary patterns and the novel inflammatory markers platelet-activating factor and lipoprotein-associated phospholipase A2: a systematic review;Nutrition Reviews;2021-10-13

2. The Effect of Rosuvastatin on Low-Density Lipoprotein Subfractions in Patients With Impaired Fasting Glucose;Journal of Cardiovascular Pharmacology and Therapeutics;2014-09-18

3. Combining Rosuvastatin With Angiotensin-Receptor Blockers of Different PPARγ-Activating Capacity;Angiology;2013-11-27

4. Fenofibrate plus simvastatin (fixed-dose combination) for the treatment of dyslipidaemia;Expert Opinion on Pharmacotherapy;2011-07-08